Fig. 2: Chest CT scan showing an irregular hyperdense mass in the right upper lobe.
interstitial inflammation (Fig. 3). There was no evidence of malignant disease. Transmission …

Amiodarone is an effective anti-arrhythmic agent. However, during long-term therapy,
patients can develop severe adverse pulmonary reactions that are potentially life …

Introduction Amiodarone is often used in the suppression of tachyarrhythmias. One of the
more serious adverse effects includes amiodarone pulmonary toxicity (APT). Several …

Following treatment with amiodarone, a patient developed weight loss, fatigue and severe
myopathy, without respiratory symptoms. A solitary lung infiltrate, impaired thyroid and liver …

A 64 year old man receiving long term amiodarone treatment presented with dyspnea,
cough, and weight loss. Radiographs and computed tomography showed a lung mass with …

A 74-year-old man, a current smoker, presented with shortness of breath and a dry cough.
He had a history of ventricular tachyarrhythmia treated with amiodarone (200 mg/d for 6 …

Rationale: Although there have been reports of pulmonary toxicity with low-dose
amiodarone, it is generally believed that low-dose therapy is safe. Methods: The clinical data …

Amiodarone is an antiarrhythmic agent commonly used to treat supraventricular and
ventricular arrhythmias. This drug is an iodine-containing compound that tends to …

Amiodarone-induced pulmonary toxicity (AIPT) is one of the most serious adverse effects of
amiodarone and is one of the leading causes of death associated with its use. The onset of …

Amiodarone is reported to cause a wide continuum of serious clinical effects. It is often
challenging to detect Amiodarone-induced pulmonary toxicity (AIPT). Typically, the …